or Try an Advanced Search...

    Technical Analysis for FHTX - Foghorn Therapeutics Inc.

    Grade Last Price % Change Price Change
    F 5.98 6.22% 0.35
    FHTX closed up 6.22 percent on Wednesday, May 8, 2024, on 67 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical FHTX trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Crossed Above 200 DMA Bullish 0.00%
    Earnings Movers Other 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Resistance Bearish 6.22%
    Fell Below 200 DMA Bearish 6.22%
    Wide Bands Range Expansion 6.22%
    Down 3 Days in a Row Weakness 6.22%
    20 DMA Resistance Bearish 2.57%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.57%
    Older End-of-Day Signals for FHTX ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Resistance about 15 hours ago
    20 DMA Resistance about 15 hours ago
    10 DMA Resistance about 15 hours ago
    Rose Above 20 DMA about 16 hours ago
    Rose Above 200 DMA about 16 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    FHTX Chart by TradingView
    Basic chart:

    Profile

    Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control™ platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology and expects to file an IND for its first program later this year.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Biology Medication

    Is FHTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Foghorn Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    May 6 Foghorn Therapeutics Q1 2024 Earnings: Misses Analyst Revenue Projections Amidst Strategic ...
    May 6 Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates
    May 6 Foghorn Therapeutics GAAP EPS of -$0.59, revenue of $5.1M
    May 6 Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update
    Apr 16 Foghorn Therapeutics appoints Kristian Humer as chief financial officer
    Apr 16 Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer
    Apr 9 Foghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Oncology Programs
    Apr 9 Foghorn Therapeutics (NASDAQ:FHTX) Is In A Good Position To Deliver On Growth Plans
    Apr 5 Foghorn Therapeutics to Participate in Needham’s 23rd Annual Virtual Healthcare Conference
    See more FHTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.96
    52 Week Low 2.7
    Average Volume 83,665
    200-Day Moving Average 5.78
    50-Day Moving Average 6.40
    20-Day Moving Average 5.86
    10-Day Moving Average 5.73
    Average True Range 0.57
    RSI (14) 50.00
    ADX 13.44
    +DI 22.49
    -DI 19.86
    Chandelier Exit (Long, 3 ATRs) 6.33
    Chandelier Exit (Short, 3 ATRs) 6.52
    Upper Bollinger Bands 7.29
    Lower Bollinger Band 4.43
    Percent B (%b) 0.54
    BandWidth 48.70
    MACD Line -0.16
    MACD Signal Line -0.21
    MACD Histogram 0.0501
    Fundamentals Value
    Market Cap 252.46 Million
    Num Shares 42.2 Million
    EPS -2.46
    Price-to-Earnings (P/E) Ratio -2.43
    Price-to-Sales 8.40
    Price-to-Book 10.71
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.69
    Resistance 3 (R3) 6.61 6.29 6.57
    Resistance 2 (R2) 6.29 6.11 6.33 6.53
    Resistance 1 (R1) 6.14 6.00 6.22 6.22 6.49
    Pivot Point 5.82 5.82 5.86 5.86 5.82
    Support 1 (S1) 5.67 5.64 5.75 5.75 5.47
    Support 2 (S2) 5.35 5.53 5.39 5.43
    Support 3 (S3) 5.20 5.35 5.39
    Support 4 (S4) 5.28